These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38191857)

  • 1. Simulated impact of mobile opioid treatment program units on increasing access to methadone for opioid use disorder.
    Gibbons JB; Li W; Stuart EA; Saloner B
    Health Serv Res; 2024 Oct; 59(5):e14271. PubMed ID: 38191857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementation of medication for opioid use disorder treatment during a natural disaster: The PROUD-LA study.
    Springgate B; Matta I; True G; Doran H; Torres WV; Stevens E; Holland E; Mott K; Ardoin TR; Nixdorff N; Haywood C; Meyers D; Johnson A; Tatum T; Palinkas LA
    J Subst Use Addict Treat; 2024 Oct; 165():209469. PubMed ID: 39094901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of Medicaid expansion on use of opioid agonist treatment and the role of provider capacity constraints.
    Gertner AK; Robertson AG; Jones H; Powell BJ; Silberman P; Domino ME
    Health Serv Res; 2020 Jun; 55(3):383-392. PubMed ID: 32166761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in Methadone Dispensing for Opioid Use Disorder After Medicare Payment Policy Changes.
    Taylor EA; Cantor JH; Bradford AC; Simon K; Stein BD
    JAMA Netw Open; 2023 May; 6(5):e2314328. PubMed ID: 37204793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pregnancy Rates Among Women Treated with Medication for Opioid Use Disorder.
    Bello JK; Xu KY; Salas J; Bedrick BS; Grucza RA
    J Gen Intern Med; 2024 Jun; 39(8):1342-1348. PubMed ID: 38424347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medications For Opioid Use Disorder Increased Among Louisiana Medicaid Enrollees During Policy Reforms, 2018-21.
    Sugarman OK; Li W; Saloner B
    Health Aff (Millwood); 2024 Jan; 43(1):46-54. PubMed ID: 38190602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes In County-Level Access To Medications For Opioid Use Disorder After Medicare Coverage Of Methadone Treatment Began.
    Harris SJ; Yarbrough CR; Abraham AJ
    Health Aff (Millwood); 2023 Jul; 42(7):991-996. PubMed ID: 37406230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Get in and get out, get on with life": Patient and provider perspectives on methadone van implementation for opioid use disorder treatment.
    Suen LW; Steiger S; Shapiro B; Castellanos S; Joshi N; Lambdin BH; Knight KR
    Int J Drug Policy; 2023 Nov; 121():104214. PubMed ID: 37778132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mobile Telemedicine for Buprenorphine Treatment in Rural Populations With Opioid Use Disorder.
    Weintraub E; Seneviratne C; Anane J; Coble K; Magidson J; Kattakuzhy S; Greenblatt A; Welsh C; Pappas A; Ross TL; Belcher AM
    JAMA Netw Open; 2021 Aug; 4(8):e2118487. PubMed ID: 34448869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mobile addiction treatment and harm reduction services as tools to address health inequities: a community case study of the Brockton Neighborhood Health Center mobile unit.
    Pinkhover A; Celata K; Baker T; Chatterjee A; Lunze K
    Front Public Health; 2024; 12():1407522. PubMed ID: 38957203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dialing for doctors: Secret shopper study of Arizona methadone and buprenorphine providers, 2022.
    Meyerson BE; Treiber D; Brady BR; Newgass K; Bondurant K; Bentele KG; Samorano S; Arredondo C; Stavros N
    J Subst Use Addict Treat; 2024 May; 160():209306. PubMed ID: 38296033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment for opioid use disorder in the Florida medicaid population: Using a cascade of care model to evaluate quality.
    Johnson K; Hills H; Ma J; Brown CH; McGovern M
    Am J Drug Alcohol Abuse; 2021 Mar; 47(2):220-228. PubMed ID: 33054435
    [No Abstract]   [Full Text] [Related]  

  • 13. Medicaid Coverage of Methadone Maintenance and the Use of Opioid Agonist Therapy Among Pregnant Women in Specialty Treatment.
    Bachhuber MA; Mehta PK; Faherty LJ; Saloner B
    Med Care; 2017 Dec; 55(12):985-990. PubMed ID: 29135769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duration of medication treatment for opioid-use disorder and risk of overdose among Medicaid enrollees in 11 states: a retrospective cohort study.
    Burns M; Tang L; Chang CH; Kim JY; Ahrens K; Allen L; Cunningham P; Gordon AJ; Jarlenski MP; Lanier P; Mauk R; McDuffie MJ; Mohamoud S; Talbert J; Zivin K; Donohue J
    Addiction; 2022 Dec; 117(12):3079-3088. PubMed ID: 35652681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rural access to MAT in Pennsylvania (RAMP): a hybrid implementation study protocol for medication assisted treatment adoption among rural primary care providers.
    Cochran G; Cole ES; Warwick J; Donohue JM; Gordon AJ; Gellad WF; Bear T; Kelley D; DiDomenico E; Pringle J
    Addict Sci Clin Pract; 2019 Aug; 14(1):25. PubMed ID: 31366408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expanding access to Medication for Opioid Use Disorder (MOUD) in jails: A comprehensive program evaluation.
    Pourtaher E; Gelberg KH; Fallico M; Ellendon N; Li S
    J Subst Use Addict Treat; 2024 Jun; 161():209248. PubMed ID: 38081540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative Effectiveness of Different Treatment Pathways for Opioid Use Disorder.
    Wakeman SE; Larochelle MR; Ameli O; Chaisson CE; McPheeters JT; Crown WH; Azocar F; Sanghavi DM
    JAMA Netw Open; 2020 Feb; 3(2):e1920622. PubMed ID: 32022884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medicare Payment for Opioid Treatment Programs.
    Nakamoto CH; Huskamp HA; Donohue JM; Barnett ML; Gordon AJ; Mehrotra A
    JAMA Health Forum; 2024 Jul; 5(7):e241907. PubMed ID: 39028654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Considerations when prescribing opioid agonist therapies for people living with HIV.
    Tarfa A; Lier AJ; Shenoi SV; Springer SA
    Expert Rev Clin Pharmacol; 2024 Jul; 17(7):549-564. PubMed ID: 38946101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initiation and Treatment Discontinuation of Medications for Opioid Use Disorder in Pregnant People Compared With Nonpregnant People.
    Xu KY; Jones HE; Schiff DM; Martin CE; Kelly JC; Carter EB; Bierut LJ; Grucza RA
    Obstet Gynecol; 2023 Apr; 141(4):845-853. PubMed ID: 36897142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.